Table 1 Baseline characteristics of patients with CHF, stratified in stages B and C.
Total patients with CHF | ||||
|---|---|---|---|---|
Variables | Total population | Stage B | Stage C | P |
N | 83 | 39.8% (33/83) | 60.2% (50/83) | |
Age (years) | 62.7 ± 12.1 | 60.4 ± 11.8 | 64.2 ± 12.2 | 0.16 |
Females | (47) 56.6% | (17) 55.4% | (30) 63.8% | 0.44 |
Arterial hypertension | (79) 95.2% | (31) 93.9% | (48) 96% | 0.66 |
Type 2 diabetes mellitus | (41) 49.4%% | (18) 54.5% | (23) 46% | 0.44 |
Sedentarism | (57) 68.7% | (18) 54.5% | (39) 78% | 0.02 |
Smoking | (12) 14.5% | (6) 18.2% | (6) 2% | 0.31 |
Ischemic Cardiopathy | (50) 60.2% | (23) 69.7% | (27) 54% | 0.15 |
BMI | 30,3 ± 7,8 | 28.7 ± 6.2 | 31.3 ± 8.7 | 0.12 |
Obesity | (33) 39,8% | (10) 30.3% | (23) 46% | 0.11 |
SBP | 134.5 ± 20.3 | 131.8 ± 18.6 | 136.2 ± 21.4 | 0.33 |
Hemoglobin (g/%) | 13.5 ± 1.4 | 11.3 ± 0.35 | 11.1 ± 0.9 | 0.76 |
Fasting blood glucose (mg/dL) | 128 ± 51.4 | 124.9 ± 45.6 | 119.6 ± 55.4 | 0.65 |
Total cholesterol (mg/dL) | 198.2 ± 49.3 | 199.7 ± 47.1 | 197.2 ± 51.2 | 0.82 |
LDL-cholesterol(mg/dL) | 122.4 ± 38.8 | 123.9 ± 40.9 | 121.4 ± 37.9 | 0.77 |
Triglycerides (mg/dL) | 164.5 ± 99.5 | 160.3 ± 97.0 | 167.3 ± 102 | 0.75 |
Serum Sodium (mEq/L) | 139.4 ± 3.3 | 138.9 ± 3.5 | 139.7 ± 3.2 | 0.26 |
Echocardiogram: LA | 43.1 ± 7.8 | 42.5 ± 6.1 | 43.6 ± 8.9 | 0.50 |
DDLV | 63.5 ± 12.6 | 61.7 ± 8.2 | 64.7 ± 14.9 | 0.30 |
EF | 37.8 ± 7.9 | 39.0 ± 6.8 | 37.0 ± 8.5 | 0.30 |
Creatinine (mg/dL) | 1.3 ± 0.8 | 1.4 ± 1 | 1.3 ± 0.6 | 0.35 |
GFR | 61.7 ± 22.9 | 61.4 ± 21.5 | 61.9 ± 24.1 | 0.90 |
Chronic kidney disease | (41) 49.4% | (14) 42.4% | (27) 54% | 0.05 |